Thanks for sharing. However, isn't typical biotech risk of delayed trials, raising capital etc. exist? I don't see clearly defined timeline to revenue.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.